Total Payments
$1,307
2024 Payments
$16.25
Companies
20
Transactions
71
Medicare Patients
961
Medicare Billing
$98,817
Payment Breakdown by Category
Food & Beverage$1,307 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,307 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $458.78 | 23 | $0 (2021) |
| PFIZER INC. | $153.01 | 12 | $0 (2020) |
| ARBOR PHARMACEUTICALS, INC. | $125.00 | 1 | $0 (2021) |
| Medtronic USA, Inc. | $120.78 | 5 | $0 (2017) |
| ABBVIE INC. | $73.45 | 5 | $0 (2024) |
| Allergan, Inc. | $67.53 | 5 | $0 (2020) |
| TerSera Therapeutics LLC | $47.14 | 2 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $38.37 | 2 | $0 (2018) |
| Nevro Corp. | $35.38 | 2 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.25 | 1 | ABBVIE INC. ($16.25) |
| 2023 | $13.78 | 1 | AbbVie Inc. ($13.78) |
| 2022 | $17.94 | 1 | ABBVIE INC. ($17.94) |
| 2021 | $211.97 | 7 | ARBOR PHARMACEUTICALS, INC. ($125.00) |
| 2020 | $186.20 | 12 | Abbott Laboratories ($94.07) |
| 2019 | $233.29 | 14 | Abbott Laboratories ($102.53) |
| 2018 | $387.60 | 21 | Abbott Laboratories ($203.39) |
| 2017 | $240.06 | 14 | Medtronic USA, Inc. ($120.78) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/16/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | BOSTON SCIENTIFIC CORPORATION | Superion (Device) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/21/2021 | Abbott Laboratories | Axium INS DRG IPG (Device) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Neuromodulation | ||||||
| 05/03/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Neuromodulation | ||||||
| 03/08/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Sleep | ||||||
| 02/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Neuromodulation | ||||||
| 12/09/2020 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $13.76 | General |
| 11/18/2020 | PFIZER INC. | FLECTOR (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/09/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/09/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Opioid Analgesic | ||||||
| 10/21/2020 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: Pain Management | ||||||
| 08/07/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/26/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/28/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/05/2020 | PFIZER INC. | LYRICA (Drug), FLECTOR | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/06/2020 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/20/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/18/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/06/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/20/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 129 | 459 | $19,617 | $8,206 |
| 2020 | 19 | 832 | 3,163 | $230,841 | $90,611 |
Total Patients
961
Total Services
3,622
Medicare Billing
$98,817
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 16 | 17 | $4,250 | $3,379 | 79.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 59 | $8,555 | $2,567 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 18 | $3,780 | $1,157 | 30.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 16 | 17 | $1,530 | $1,056 | 69.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 20 | 295 | $1,475 | $33.34 | 2.3% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2021 | 15 | 53 | $26.50 | $13.52 | 51.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 220 | 405 | $58,725 | $21,321 | 36.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 119 | 167 | $35,070 | $13,015 | 37.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 32 | 50 | $12,500 | $9,889 | 79.1% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2020 | 14 | 71 | $18,460 | $9,069 | 49.1% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Office | 2020 | 18 | 38 | $16,150 | $7,006 | 43.4% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Office | 2020 | 30 | 43 | $13,860 | $5,134 | 37.0% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2020 | 37 | 61 | $17,080 | $4,520 | 26.5% |
| 80307 | Testing for presence of drug | Office | 2020 | 33 | 52 | $4,680 | $3,215 | 68.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 44 | 45 | $9,450 | $3,137 | 33.2% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Office | 2020 | 12 | 23 | $7,705 | $3,117 | 40.5% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 36 | 59 | $7,080 | $2,643 | 37.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2020 | 34 | 50 | $6,035 | $2,469 | 40.9% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance | Office | 2020 | 12 | 22 | $3,740 | $1,544 | 41.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 14 | $3,990 | $1,502 | 37.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,575 | $1,306 | 36.5% |
| 97162 | Evaluation of physical therapy, typically 30 minutes | Office | 2020 | 13 | 13 | $2,080 | $862.83 | 41.5% |
| 62367 | Electronic analysis of spinal canal drug infusion pump | Office | 2020 | 16 | 25 | $2,125 | $605.72 | 28.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 72 | 1,673 | $8,365 | $165.63 | 2.0% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2020 | 65 | 341 | $170.50 | $89.84 | 52.7% |
About Dr. Richard Donnini, D.O
Dr. Richard Donnini, D.O is a Interventional Pain Medicine healthcare provider based in Centerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316912413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Donnini, D.O has received a total of $1,307 in payments from pharmaceutical and medical device companies, with $16.25 received in 2024. These payments were reported across 71 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,307).
As a Medicare-enrolled provider, Donnini has provided services to 961 Medicare beneficiaries, totaling 3,622 services with total Medicare billing of $98,817. Data is available for 2 years (2020–2021), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Centerville, OH
- Active Since 02/22/2006
- Last Updated 11/09/2015
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1316912413
Products in Payments
- Proclaim Family of SCS IPGs (Device) $323.88
- LYRICA (Drug) $127.16
- Horizant (Drug) $125.00
- MYSTIM (Device) $79.29
- UBRELVY (Drug) $56.81
- Prodigy Family of SCS IPGs (Device) $49.66
- PRIALT (Drug) $47.14
- SCS IPGs (Device) $42.99
- Prialt (Drug) $38.37
- Senza Spinal Cord Stimulation System (Device) $35.38
- RELISTOR ORAL (Drug) $32.00
- Proclaim IPG (Device) $28.75
- ADAPTIVESTIM (Device) $28.16
- BOTOX-NEUROLOGY (Drug) $25.47
- Superion (Device) $19.24
- BOTOX (Biological) $17.94
- EVZIO (Drug) $16.72
- XTAMPZA (Drug) $16.00
- QULIPTA (Drug) $13.74
- BOTOX THERAPEUTIC - HH (Biological) $13.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.